Inventor
LINNAU YENDRA
AT39 patents
⚠️ This page may combine multiple inventors who share the name “LINNAU YENDRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNO AG
35 patentsUS5608038AMar 4, 1997
Highly concentrated immunoglobulin preparation and method for its production
IMMUNO AG134 citations98
US4600574AJul 15, 1986
Method of producing a tissue adhesive
IMMUNO AG174 citations98
US4414976ANov 15, 1983
Tissue adhesive
IMMUNO AG205 citations98
US4377572AMar 22, 1983
Tissue adhesive
IMMUNO AG325 citations98
US4362567ADec 7, 1982
Tissue adhesive
IMMUNO AG250 citations98
US4298598ANov 3, 1981
Tissue adhesive
IMMUNO AG225 citations98
US5714370AFeb 3, 1998
Thrombin and method of producing the same
IMMUNO AG74 citations96
US5122373AJun 16, 1992
Immunoglobulin-g-containing fraction
IMMUNO AG57 citations96
US4640834AFeb 3, 1987
Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood products
IMMUNO AG144 citations96
US5478558ADec 26, 1995
Method of dissolving venous Thrombi using drug containing activated Protein C
IMMUNO AG29 citations92
US4814435AMar 21, 1989
Method of producing a factor VIII (AHF) containing fraction
IMMUNO AG31 citations92
US4522751AJun 11, 1985
Method for producing a preparation containing factor VIII (AHF)
IMMUNO AG34 citations92
US4404131ASep 13, 1983
Method of producing a factor-VIII(AHF)-high-concentrate
IMMUNO AG39 citations92
US5410022AApr 25, 1995
Method of producing a factor VIII preparation
IMMUNO AG26 citations91
US4904641AFeb 27, 1990
Method of inactivating reproducible filterable pathogens in blood plasma products
IMMUNO AG24 citations91
US5864016AJan 26, 1999
Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
IMMUNO AG21 citations90
US5614405AMar 25, 1997
Method of determining the virus inactivation capacity of an inactivation treatment
IMMUNO AG20 citations90
US5833984ANov 10, 1998
Composition and method for preventing and treating inflammation with Immunoglobulin A
IMMUNO AG38 citations89
US4608254AAug 26, 1986
Method for the production of therapeutically administrable plasma derivatives filled in final containers
IMMUNO AG21 citations82
US4388232AJun 14, 1983
Method of producing plasma fractions free of side-effects using fast-reacting antithrombin
IMMUNO AG22 citations81
US4276283AJun 30, 1981
Method of preparing an intravenously administrable immune globulin preparation containing antibodies and preparations produced according to this method
IMMUNO AG21 citations81
US5371007ADec 6, 1994
Method of producing lys-plasminogen
IMMUNO AG19 citations80
US5409990AApr 25, 1995
Complex containing coagulation factor IX
IMMUNO AG16 citations78
US5393666AFeb 28, 1995
Method of activating prothrombin
IMMUNO AG15 citations74
US5094949AMar 10, 1992
Use of chymotrypsin for the inactivation of prekallikrein activator
IMMUNO AG10 citations74
US4814277AMar 21, 1989
Method of inactivating reproductive filterable pathogens
IMMUNO AG13 citations74
US5580962ADec 3, 1996
Parenterally administrable drug having thrombolytic activity and containing protein C
IMMUNO AG8 citations73
US4510084AApr 9, 1985
Method of producing an antithrombin III-heparin concentrate or antithrombin III-heparinoid concentrate
IMMUNO AG13 citations72
US5281661AJan 25, 1994
Complex containing coagulation factor IX
IMMUNO AG12 citations70
US5254532AOct 19, 1993
Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
IMMUNO AG16 citations70
US5143901ASep 1, 1992
Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
IMMUNO AG6 citations70
US5234685AAug 10, 1993
Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances
IMMUNO AG4 citations63
US4886758ADec 12, 1989
Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances
IMMUNO AG3 citations63
US5556766ASep 17, 1996
Method of producing LYS-plasminogen
IMMUNO AG4 citations60
US5324628AJun 28, 1994
Use of chymotrypsin for the inactivation of prekallikrein activator
IMMUNO AG0 citations52
BAXTER AG
3 patentsUS6307032B1Oct 23, 2001
Highly purified factor VIII complex
BAXTER AG15 citations83
US6395880B1May 28, 2002
Method for purification of antithrombin III using an anion exchanger
BAXTER AG11 citations68
US6605222B1Aug 12, 2003
Method for producing a factor VIII/von Willebrand factor complex
BAXTER AG0 citations50